| Dr Marc J Kayem, MD | |
|
465 N Roxbury Dr, Suite 1001, Beverly Hills, CA 90210-4206 | |
| (310) 248-6250 | |
| Not Available |
| Full Name | Dr Marc J Kayem |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 37 Years |
| Location | 465 N Roxbury Dr, Beverly Hills, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467653972 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | A49693 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mammoth Hospital | Mammoth lakes, CA | Hospital |
| Cedar-sinai Marina Del Rey Hospital | Marina del rey, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Marc J Kayem Md Inc | 2264428937 | 2 |
| Marc J Kayem Md Inc | 2264428937 | 2 |
| Southern Mono Health Care District | 9830002401 | 65 |
News Archive
By developing a novel decoding technology, a team of engineers and physicians at the University of Southern California and UC San Francisco have discovered how mood variations can be decoded from neural signals in the human brain-a process that has not been demonstrated to date.
IntraPace, announced today that it has received European CE Mark approval for the abiliti system as a treatment for obesity. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.
Researchers from Germany recently analyzed a cohort of 26 individuals in the age range of 25 to 46 (median 30.5) years who had received a ChAdOx1 nCoV-19 prime vaccine followed by a BNT162b2 boost vaccine after a 56-day interval due to changing vaccine recommendations in Germany. There were 16 females and 10 males in the cohort, and they were assessed for immune responses, reactogenicity, and T cell reactivity. This study is published on the medRxiv* preprint server.
Cochlear, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Nucleus((R) )5 System for adults and children with severe-to-profound hearing loss.
Tobacco companies poured nearly $47 million into defeating Proposition 29, a $1-a-pack tax hike on cigarettes, but the measure was narrowly leading in early returns Tuesday despite the hard-fought campaign. The tax increase would raise $810 million a year for cancer research and smoking cessation programs, and it would give California - which currently has a lower tobacco tax than 32 other states - the 16th-highest cigarette tax in the nation. … The vote would be a huge win for the public health groups that sponsored the measure, including the American Cancer Society.
› Verified 7 days ago
| Entity Name | Southern Mono Health Care District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962444059 PECOS PAC ID: 9830002401 Enrollment ID: O20031118001160 |
News Archive
By developing a novel decoding technology, a team of engineers and physicians at the University of Southern California and UC San Francisco have discovered how mood variations can be decoded from neural signals in the human brain-a process that has not been demonstrated to date.
IntraPace, announced today that it has received European CE Mark approval for the abiliti system as a treatment for obesity. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.
Researchers from Germany recently analyzed a cohort of 26 individuals in the age range of 25 to 46 (median 30.5) years who had received a ChAdOx1 nCoV-19 prime vaccine followed by a BNT162b2 boost vaccine after a 56-day interval due to changing vaccine recommendations in Germany. There were 16 females and 10 males in the cohort, and they were assessed for immune responses, reactogenicity, and T cell reactivity. This study is published on the medRxiv* preprint server.
Cochlear, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Nucleus((R) )5 System for adults and children with severe-to-profound hearing loss.
Tobacco companies poured nearly $47 million into defeating Proposition 29, a $1-a-pack tax hike on cigarettes, but the measure was narrowly leading in early returns Tuesday despite the hard-fought campaign. The tax increase would raise $810 million a year for cancer research and smoking cessation programs, and it would give California - which currently has a lower tobacco tax than 32 other states - the 16th-highest cigarette tax in the nation. … The vote would be a huge win for the public health groups that sponsored the measure, including the American Cancer Society.
› Verified 7 days ago
| Entity Name | Marc J Kayem Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922043710 PECOS PAC ID: 2264428937 Enrollment ID: O20040420001878 |
News Archive
By developing a novel decoding technology, a team of engineers and physicians at the University of Southern California and UC San Francisco have discovered how mood variations can be decoded from neural signals in the human brain-a process that has not been demonstrated to date.
IntraPace, announced today that it has received European CE Mark approval for the abiliti system as a treatment for obesity. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.
Researchers from Germany recently analyzed a cohort of 26 individuals in the age range of 25 to 46 (median 30.5) years who had received a ChAdOx1 nCoV-19 prime vaccine followed by a BNT162b2 boost vaccine after a 56-day interval due to changing vaccine recommendations in Germany. There were 16 females and 10 males in the cohort, and they were assessed for immune responses, reactogenicity, and T cell reactivity. This study is published on the medRxiv* preprint server.
Cochlear, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Nucleus((R) )5 System for adults and children with severe-to-profound hearing loss.
Tobacco companies poured nearly $47 million into defeating Proposition 29, a $1-a-pack tax hike on cigarettes, but the measure was narrowly leading in early returns Tuesday despite the hard-fought campaign. The tax increase would raise $810 million a year for cancer research and smoking cessation programs, and it would give California - which currently has a lower tobacco tax than 32 other states - the 16th-highest cigarette tax in the nation. … The vote would be a huge win for the public health groups that sponsored the measure, including the American Cancer Society.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marc J Kayem, MD 465 N. Roxbury Dr #1001, Suite 340, Beverly Hills, CA 90210-1800 Ph: (310) 248-6250 | Dr Marc J Kayem, MD 465 N Roxbury Dr, Suite 1001, Beverly Hills, CA 90210-4206 Ph: (310) 248-6250 |
News Archive
By developing a novel decoding technology, a team of engineers and physicians at the University of Southern California and UC San Francisco have discovered how mood variations can be decoded from neural signals in the human brain-a process that has not been demonstrated to date.
IntraPace, announced today that it has received European CE Mark approval for the abiliti system as a treatment for obesity. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.
Researchers from Germany recently analyzed a cohort of 26 individuals in the age range of 25 to 46 (median 30.5) years who had received a ChAdOx1 nCoV-19 prime vaccine followed by a BNT162b2 boost vaccine after a 56-day interval due to changing vaccine recommendations in Germany. There were 16 females and 10 males in the cohort, and they were assessed for immune responses, reactogenicity, and T cell reactivity. This study is published on the medRxiv* preprint server.
Cochlear, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Nucleus((R) )5 System for adults and children with severe-to-profound hearing loss.
Tobacco companies poured nearly $47 million into defeating Proposition 29, a $1-a-pack tax hike on cigarettes, but the measure was narrowly leading in early returns Tuesday despite the hard-fought campaign. The tax increase would raise $810 million a year for cancer research and smoking cessation programs, and it would give California - which currently has a lower tobacco tax than 32 other states - the 16th-highest cigarette tax in the nation. … The vote would be a huge win for the public health groups that sponsored the measure, including the American Cancer Society.
› Verified 7 days ago
Sohit Paul Kanotra, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 9675 Brighton Way Ste 100, Beverly Hills, CA 90210 Phone: 310-205-7310 | |
Dr. William Crawford Harris, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 9090 Burton Way, Beverly Hills, CA 90211 Phone: 310-880-2117 | |
Richard William Fleming, Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 416 N Bedford Dr # 200, Beverly Hills, CA 90210 Phone: 310-278-8823 Fax: 310-278-2671 | |
Babak Azizzadeh, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 8670 Wilshire Blvd, Suite 200, Beverly Hills, CA 90211 Phone: 310-657-2253 Fax: 310-657-0776 | |
Vanessa Shana Rothholtz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 414 N Camden Dr Ste 975, Beverly Hills, CA 90210 Phone: 310-926-1573 Fax: 310-926-1563 | |
Vanessa Christopher, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 201 S Lasky Dr, Beverly Hills, CA 90212 Phone: 310-277-4572 | |
Dr. Amy K Hsu, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 9440 Santa Monica Blvd Ste 408, Beverly Hills, CA 90210 Phone: 310-800-2371 Fax: 877-991-4918 |